Clinical trial

Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the…

NCT00107484 · Virginia Commonwealth University, Other · Completed

Key facts

NCT number NCT00107484
Title Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
Official title Phase II Study of Combidex in Axillary Node Staging in Breast Cancer
Lead sponsor Virginia Commonwealth University, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Breast Cancer
Intervention type Drug, Procedure
Interventions ferumoxtran-10, magnetic resonance imaging, sentinel lymph node biopsy
Enrollment 3
Start date Sep 1, 2005
Primary completion Oct 1, 2006
Completion Oct 1, 2006
First posted Apr 6, 2005
Last update posted May 3, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies